NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)

Technical Analysis Report for USA stock MBRX Moleculin Biotech. Dated: 05 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech

Moleculin Biotech Opened at 2.30 and Closed at: 2.24, which is -4.46% of previous session's close. It moved within a range of 2.24 and 2.35
The session was a Bearish session with an average volume of 73900, which is -14.88% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 2.19 and resistance for tomorrow is 2.3
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.2, 2.17 resistance for tomorrow's hourly charts is 2.31, 2.39

10 Day SMA for Moleculin Biotech (MBRX) is 2.38 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Moleculin Biotech (MBRX) is 3.28 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Moleculin Biotech (MBRX) is 3.78 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.94 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Moleculin Biotech is 1.76 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Moleculin Biotech is at 3.28 and 200 DMA is at 1.76, while 50 DMA and 100 DMA are at 3.78 and 2.94 respectively

Moleculin Biotech (MBRX) moving average of 20 SMA is at 3.28 and 20 EMA is at 3.02

Moleculin Biotech (MBRX) moving average of 50 SMA is at 3.78 and 50 EMA is at 3.39

Moleculin Biotech (MBRX) moving average of 100 SMA is at 2.94 and 100 EMA is at 3.04

Moleculin Biotech (MBRX) moving average of 200 SMA is at 1.76 and 200 EMA is at 2.42

Takeda Pharmaceutical has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 47.3% more returns!

Merck Company has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Merck Company, about 43.26% more returns!

Haemonetics Corporation has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 56.27% more returns!

Cigna Corporation has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cigna Corporation, about 44.34% more returns!

Therapeuticsmd Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 45.41% more returns!

Supernus Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 53.1% more returns!

Rigel Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 34.47% more returns!

Radnet Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Radnet Inc, about 44.32% more returns!

Pro Dex has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Pro Dex, about 68.71% more returns!

Myriad Genetics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Myriad Genetics, about 48.23% more returns!

Lantheus Holdings has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Lantheus Holdings, about 65.63% more returns!

Krystal Biotech has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Krystal Biotech, about 43.48% more returns!

Galmed Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Galmed Pharmaceuticals, about 43.48% more returns!

Eton Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 64.83% more returns!

Cytomx Therapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cytomx Therapeutics, about 32.16% more returns!

Compugen has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Compugen, about 70.78% more returns!

Alkermes Plc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Alkermes Plc, about 29.24% more returns!

Moleculin Biotech Technical analysis of indicators

Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Moleculin Biotech stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Moleculin Biotech in short term and the sell signal is strong.

Moleculin Biotech Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Moleculin Biotech in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Moleculin Biotech is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.41 and Moleculin Biotech MBRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.

Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And MBRX Experts View which covers a lot of information including buying and selling signals

MBRX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet